Absolute circulating leukemic cells as a risk factor for early bleeding events in patients with non-high-risk acute promyelocytic leukemia
Cancer Management and Research May 28, 2021
Pei Y, Shi M, Song J, et al. - Researchers sought to determine the role of the absolute number of circulating leukemic cells in early bleeding events in patients suffering from acute promyelocytic leukemia (APL). Participants were 149 patients newly diagnosed with APL, from whom clinical and laboratory characteristics were collected using medical records and retrospectively examined. In multivariate logistic regression analysis, the absolute number of leukemia cells was identified as an independent risk factor for significant bleeding events in APL cases. According to receiver operating characteristic curve analysis, significant bleeding events in APL were predicted by circulating leukemic cells at a cut-off value of 2.59× 10 9 /L. Findings demonstrate great clinical value of circulating leukemic cell content for predicting early bleeding events in APL cases, particularly in non-high-risk APL.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries